← Back to Search

Deep Brain Stimulation and Decision-Making Tasks for Parkinson's Disease (MPPN Trial)

N/A
Recruiting
Led By Simon J Little, MBBS, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers learn more about how Parkinson's patients make decisions, in hopes of improving treatments for the disease.

Who is the study for?
This trial is for Parkinson's patients who already have a Medtronic Percept PC DBS device implanted. It's not suitable for those with severe cognitive impairments.
What is being tested?
The study examines how deep brain stimulation (DBS) affects motivation and decision-making in Parkinson's patients, using tasks with the stimulation turned on and off.
What are the potential side effects?
While this study isn't testing a drug, side effects may include discomfort or changes in mood or behavior due to varying levels of brain stimulation during the tasks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years
This trial's timeline: 3 weeks for screening, Varies for treatment, and the values will be collected starting from admission in clinic and the at-home paradigm. data collection and analysis of said values can take up to three years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent of Risky Decisions made with Percept PC DBS stimulation off for Parkinson's Disease Patients
Parkinson Disease

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: StimulationExperimental Treatment2 Interventions
Patients will be getting standard clinically acceptable stimulation within already safety validated stimulation ranges through their Medtronic Percept PC device.
Group II: No StimulationExperimental Treatment2 Interventions
Patients will have stimulation turned off through their Medtronic Percept PC device.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,590 Previous Clinical Trials
14,901,383 Total Patients Enrolled
Yale UniversityOTHER
1,927 Previous Clinical Trials
3,031,712 Total Patients Enrolled
Rune LabsUNKNOWN
Simon J Little, MBBS, PhDPrincipal InvestigatorUniversity of California, San Francisco

Media Library

Decision Making Task Clinical Trial Eligibility Overview. Trial Name: NCT05065151 — N/A
Deep Brain Stimulation Research Study Groups: No Stimulation, Stimulation
Deep Brain Stimulation Clinical Trial 2023: Decision Making Task Highlights & Side Effects. Trial Name: NCT05065151 — N/A
Decision Making Task 2023 Treatment Timeline for Medical Study. Trial Name: NCT05065151 — N/A
Deep Brain Stimulation Patient Testimony for trial: Trial Name: NCT05065151 — N/A
~5 spots leftby Dec 2025